This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,614.68 delivery order is for the pharmaceutical product OPZELURA 1.5% Cream 60GM. The contract has a firm fixed price and an ultimate completion date of June 21, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA to provide...
This is a $9,971.49 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the pharmaceutical product OPZELURA 1.5% Cream in 60g containers, with a period of performance through August 12, 2024. The contract has no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, is supplying this product under one of its Indefinite Delivery Contracts with DLA Troop Support Medical,...
This is a $3,612.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of OPZELURA 1.5% cream in 60g quantities. The contract has an ultimate completion date of September 11, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $1,395.71 Firm Fixed Price contract is for the supply of OPZELURA 1.5% Cream (60g), a prescription dermatological product. The contract has an ultimate completion date of July 31, 2024. AmerisourceBergen is a long-standing supplier to the DLA Troop Support Medical program, providing a wide range of pharmaceutical and medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,437.27, is for the delivery of OPZELURA 1.5% CREAM 60GM. It has an ultimate completion date of June 6, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical and medical supply distributor, for the delivery of the prescription medication OPZELURA 1.5% cream. The $32,541.06 delivery order was issued by the Medical Supply Chain of the Defense Logistics Agency (DLA) and has a completion date of November 1, 2022. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, through its Corporate Office division, has extensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,911.04, is for the delivery of OPZELURA 1.5% Cream 60GM, a pharmaceutical product. The contract has a completion date of December 19, 2024 and is a firm-fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor for this award and the company is registered in the System for...
This is a delivery order award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) for the pharmaceutical product OPZELURA 1.5% Cream, 60 grams. The firm-fixed-price contract is valued at $11,433.56 with an ultimate completion date of August 27, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,636.76, is for the delivery of OPZELURA 1.5% cream in 60-gram tubes. The award has an ultimate completion date of January 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This is a $1,758.38 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product, with a period of performance through June 26, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...